Latest News

Check out what is happening at HCD Economics

May 2025

Unlocking Insights: NICE Introduces New Guidance on Qualitative Research

At the start of 2025, NICE updated its real-world evidence (RWE) framework on guidance for qualitative studies, showing NICE’s increasing openness to qualitative evidence submissions, particularly in rare conditions where RWE can be scarce. A new appendix dedicated to planning, conducting and reporting qualitative research to support NICE decision-making was introduced.
Continue Reading
March 2025

Advocating for Greater Patient-Centred Approaches in Clinical Trial Design

Clinical endpoints are critical in evaluating the effectiveness of new treatments. Traditionally, endpoints in trials have focused on objective, clinical measures of disease. However, these endpoints do not always capture patient experiences, treatment burden, or quality of life factors that may influence treatment adherence and overall outcomes.
Continue Reading
Scroll for more

About us

HCD was created out of an alliance with University of Chester, charities and health service sectors in reponse to the ever-growing demand for economic analysis within healthcare and specifically the need for health economics and business intelligence within the public and third sectors.

Through these partnerships, HCD provides a unique insight and perspective, focusing our analyses on what matters to patients as well as decision-makers, all undertaken with academic rigour, independence and credibility.

Continue Reading
Scroll for more

Our Process

We have created core partnerships with University of Chester and leading patient charities that underpin our approach.

Higher education

Academia has a leading role to play in providing an independent, credible evidence-base as well as evaluating current and new ways of delivering healthcare.

Charities

Our partnerships with patient charities ensure that any analyses we undertake reflect the day-to-day realities of living with a particular condition.

Data

We apply primary or secondary real world data sources depending on research needs and questions. From ethically reviewed burden of illness studies and bespoke service primary data, to secondary sourced disease registries and episode statistics.

Scroll for more

Get in touch

...and one of our experts will get back to you ASAP.

Please be advised that we will not use your details for marketing purposes
Scroll for more

Data

How we manage your data
Scroll for more